# BioCubaFarma

Source: https://onco.cc/companies/biocubafarma/  
OnCo record `biocubafarma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cuba's group of biotechnology and pharmaceutical enterprises. A 2023 report gave the national industry as responsible for 61% of the medicines on Cuba's basic list; the group lists cancer monoclonal antibodies and therapeutic vaccines among its main products, and has told parliament that missing raw materials cause most shortages.

## Summary

BioCubaFarma's own description (July 2025) is of a business organisation that produces medicines, equipment and high-technology services for human health, for export and for food production, with 47 enterprises, 164 production lines, 21 science and technology units and 16,490 workers, 265 of them with doctorates. Among its main products it lists prophylactic vaccines and biopharmaceuticals for cancer such as monoclonal antibodies and therapeutic vaccines; it also makes generic medicines and systems for early diagnosis and prevention of malignant tumours. Its head office is at Avenida Independencia No. 8126, Boyeros, Havana.

Granma's report of a National Assembly session, republished by the Pinar del Río newspaper Guerrillero on 28 July 2023, said 251 medicines (40% of the basic list) were missing and described the national industry as responsible for 61% of the list. BioCubaFarma's president Eduardo Martínez Díaz told the session that missing raw materials and materials caused 94% of shortages. He gave as causes a lack of timely financing, problems paying suppliers because banks refused to work with Cuba, usual suppliers stopping because of the US economic embargo, and global shortages of some materials. Of 14 oncology products, five were affected at the end of June 2023: cisplatin, carboplatin, vinblastine, paclitaxel and zoledronic acid.

## Fields

- Kind: Company
- Last checked: 2026-11-11
- Also known as: Grupo de las Industrias Biotecnológica y Farmacéutica de Cuba; BioCubaFarma Group
- HQ: Havana
- Type: pharma
- Website: https://www.biocubafarma.cu

## Sources

- BioCubaFarma: about us (Spanish; read through the Internet Archive): https://web.archive.org/web/2025/https://www.biocubafarma.cu/es/nosotros
- Granma, republished by Guerrillero: medicine supply report to the National Assembly (28 July 2023; read through the Internet Archive): https://web.archive.org/web/2025/https://guerrillero.cu/sigue-siendo-compleja-la-disponibilidad-de-medicamentos

## Connected records

- companies: [CIMAB](https://onco.cc/companies/cimab/)
- institutions: [Ministry of Public Health, Cuba (MINSAP)](https://onco.cc/institutions/cuba-minsap/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/), [Vinblastine](https://onco.cc/drugs/vinblastine/), [Zoledronic acid](https://onco.cc/drugs/zoledronic-acid/)

---
JSON: https://onco.cc/api/v1/entities/biocubafarma.json